Patents by Inventor Thomas Peter Sabroe

Thomas Peter Sabroe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stereoselective synthesis of vitamin D analogues
    Patent number: 8759555
    Abstract: The present invention relates to intermediates useful for the synthesis of calcipotriol or calcipotriol monohydrate, to methods of producing said intermediates, and to methods of stereoselectively reducing said intermediates.
    Type: Grant
    Filed: June 26, 2012
    Date of Patent: June 24, 2014
    Assignee: Leo Pharma A/S
    Inventors: Thomas Peter Sabroe, Martin John Calverley
  • Stereoselective synthesis of vitamin D analogues
    Patent number: 8362287
    Abstract: The present invention relates to intermediates useful for the synthesis of calcipotriol or calcipotriol monohydrate, to methods of producing said intermediates, and to methods of stereoselectively reducing said intermediates.
    Type: Grant
    Filed: March 10, 2005
    Date of Patent: January 29, 2013
    Assignee: Leo Pharma A/S
    Inventors: Thomas Peter Sabroe, Martin John Calverley
  • STEREOSELECTIVE SYNTHESIS OF VITAMIN D ANALOGUES
    Publication number: 20120271058
    Abstract: The present invention relates to intermediates useful for the synthesis of calcipotriol or calcipotriol monohydrate, to methods of producing said intermediates, and to methods of stereoselectively reducing said intermediates.
    Type: Application
    Filed: June 26, 2012
    Publication date: October 25, 2012
    Inventors: Thomas Peter SABROE, Martin John Calverley
  • Aminobenzophenone compounds
    Patent number: 7977387
    Abstract: The invention provides novel compounds according to formula I relates to compounds with the general formula I said compounds being useful, e.g. in the treatment of inflammatory, ophthalmic diseases or cancer.
    Type: Grant
    Filed: July 9, 2004
    Date of Patent: July 12, 2011
    Assignee: Leo Pharma A/S
    Inventors: Erik Rytter Ottosen, Anne Marie Horneman, Xifu Liang, Søren Christian Schou, Sophie Elisabeth Havez, Thomas Peter Sabroe